Skip to main content
Log in

Effect of methylene blue-mediated photodynamic therapy for treatment of basal cell carcinoma

  • Original Article
  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

Photodynamic therapy (PDT) is regarded as a treatment option for basal cell carcinoma (BCC). The aim of this study is to investigate the efficacy of methylene blue (MB)-based PDT in patients suffering from nodular or ulcerative BCCs. This study is a prospective clinical trial with a 6-months follow-up. The study setting is at the Dermatology Clinic at NILES, Cairo University, Egypt. Seventeen patients complaining of nodular BCC (nBCC) and three patients complaining of ulcerative BCC (uBCC) were taken as samples. Methylene blue, the photosensitizer, was prepared in two different formulas: liposomal-loaded MB (LMB) was prepared and formulated in hydrogel (MB 0.2 %) to be used topically alone for treating BCCs <2 cm in diameter or to be combined with intralesional injection (ILI) of free MB 2 % aqueous solution for treating BCCs ≥2 cm in diameter. A session was performed every 2 weeks until complete response (CR) of the lesion or for a maximum of six sessions. Clinical assessments of clinical improvement, dermatological photography, monthly follow-up visits for 6 months, and skin biopsy after 3 months of follow-up to confirm the response, recurrence, or both in cases in which the clinical evaluation was ambiguous. Seventeen patients of the 20 completed the study, 11 patients achieved CR with very good cosmetic outcome, photosensitizer tolerance, and minimal reported side effects. MB is a cheap promising alternative photosensitizer for PDT of nBCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Miller DL, Weinstock MA (1994) Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 30(5 Pt 1):774–778

    Article  CAS  PubMed  Google Scholar 

  2. Franceschi S et al (1996) Site distribution of different types of skin cancer: new aetiological clues. Int J Cancer 67(1):24–28

    Article  CAS  PubMed  Google Scholar 

  3. Owens DM, Watt FM (2003) Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer 3:444–451

    Article  CAS  PubMed  Google Scholar 

  4. Epstein EH (2008) Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 8:743–754

    Article  CAS  PubMed  Google Scholar 

  5. Scrivener Y, Grosshans E, Cribier B (2002) Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 147(1):41–47

    Article  CAS  PubMed  Google Scholar 

  6. Kwasniak LA, Garcia-Zuazaga J (2011) Basal cell carcinoma: evidence-based medicine and review of treatment modalities. Int J Dermatol 50(6):645–658

    Article  PubMed  Google Scholar 

  7. Taub AF (2004) Photodynamic therapy in dermatology: history and horizons. J Drugs Dermatol 3(1 Suppl):S8–S25

    PubMed  Google Scholar 

  8. Calzavara-Pinton PG, Venturini M, Sala R (2007) Photodynamic therapy: update 2006. Part 1: photochemistry and photobiology. J Eur Acad Dermatol Venereol 21(3):293–302

    Article  CAS  PubMed  Google Scholar 

  9. Wainwright M, Crossley KB (2002) Methylene Blue–a therapeutic dye for all seasons? J Chemother 14(5):431–443

    Article  CAS  PubMed  Google Scholar 

  10. Rhodes LE et al (2007) 5-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs. surgery for nodular basal cell carcinoma. Arch Dermatol 143(9):1131–1136

    Article  CAS  PubMed  Google Scholar 

  11. Rhodes LE et al (2004) Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 140(1):17–23

    Article  CAS  PubMed  Google Scholar 

  12. SamarasingheV, Madan V, and Lear JT (2011) Focus on Basal cell carcinoma. J Skin Cancer 2011: p. 328615

  13. Horn M et al (2003) Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 149(6):1242–1249

    Article  CAS  PubMed  Google Scholar 

  14. Cosgarea R, et al. (2012) Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma. J Eur Acad Dermatol Venereol 28(6):0926–9959

  15. Gupta AK, Ryder JE (2003) Photodynamic therapy and topical aminolevulinic acid: an overview. Am J Clin Dermatol 4(10):699–708

    Article  PubMed  Google Scholar 

  16. Junqueira HC et al (2002) Modulation of methylene blue photochemical properties based on adsorption at aqueous micelle interfaces. Phys Chem Chem Phys 4(11):2320–2328

    Article  CAS  Google Scholar 

  17. Noodt BB (1996) Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. Br J Cancer 74(1):22–29

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Wiegell SR, Wulf HC (2006) Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial. Br J Dermatol 154(5):969–976

    Article  CAS  PubMed  Google Scholar 

  19. Tardivo JP et al (2005) Methylene blue in photodynamic therapy: from basic mechanisms to clinical applications. Photodiagn Photodyn Ther 2(3):175–191

    Article  CAS  Google Scholar 

  20. Morton CA et al (2002) Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 146(4):552–567

    Article  CAS  PubMed  Google Scholar 

  21. Muehlmann LA et al (2011) Liposomal photosensitizers: potential platforms for anticancer photodynamic therapy. Braz J Med Biol Res 44(8):729–737

    Article  CAS  PubMed  Google Scholar 

  22. Gulati M et al (1998) Lipophilic drug derivatives in liposomes. Int J Pharm 165(2):129–168

    Article  CAS  Google Scholar 

  23. Gerritsen MJ et al (2009) Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy. Dermatology 218(3):193–202

    Article  CAS  PubMed  Google Scholar 

  24. Rodriguez-Prieto MA et al (2012) Photodynamic therapy with intralesional photosensitizer and laser beam application: an alternative treatment for nodular basal cell carcinoma. J Am Acad Dermatol 67(4):e134–e136

    Article  PubMed  Google Scholar 

  25. Sotiriou E, Apalla Z, Ioannides D (2010) Complete resolution of a squamous cell carcinoma of the skin using intralesional 5-aminolevulinic acid photodynamic therapy intralesional PDT for SCC. Photodermatol Photoimmunol Photomed 26(5):269–271

    Article  PubMed  Google Scholar 

  26. Kim JE et al (2012) New proposal for the treatment of viral warts with intralesional injection of 5-aminolevulinic acid photodynamic therapy. J Dermatol Treat 23(3):192–195

    Article  CAS  Google Scholar 

  27. Kim SK, Shin J, Kim YC (2012) Nodular basal cell carcinoma successfully treated with intralesional 5-aminolevulinic acid injection-photodynamic therapy. Ann Dermatol 24(4):486–487

    Article  PubMed Central  PubMed  Google Scholar 

  28. Evangelou G et al (2011) Successful treatment of cutaneous leishmaniasis with intralesional aminolevulinic acid photodynamic therapy. Photodermatol Photoimmunol Photomed 27(5):254–256

    Article  PubMed  Google Scholar 

  29. Lee DJ et al (2012) Photodynamic therapy with 5-aminolevulinic acid intralesional injection for pyogenic granuloma. Arch Dermatol 148(1):126–128

    Article  CAS  PubMed  Google Scholar 

  30. Shaaban D, Abdel-Samad Z, El-Khalawany M (2012) Photodynamic therapy with intralesional 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone in the treatment of acne vulgaris: a comparative study. Dermatol Ther 25(1):86–91

    Article  PubMed  Google Scholar 

  31. Orth K et al (2000) Methylene blue mediated photodynamic therapy in experimental colorectal tumors in mice. J Photochem Photobiol B 57(2–3):186–192

    Article  CAS  PubMed  Google Scholar 

  32. Orth K et al (1998) Photochemotherapy of experimental colonic tumours with intra-tumorally applied methylene blue. Langenbeck’s Arch Surg 383(3–4):276–281

    Article  CAS  Google Scholar 

  33. Berroeta L et al (2007) A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma. Br J Dermatol 157(2):401–403

    Article  CAS  PubMed  Google Scholar 

  34. Szeimies RM et al (1994) A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. Acta Derm Venereol 74(2):117–119

    CAS  PubMed  Google Scholar 

  35. Clark C et al (2003) Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 19(3):134–141

    Article  CAS  PubMed  Google Scholar 

  36. Baran TM et al (2010) Factors influencing tumor response to photodynamic therapy sensitized by intratumor administration of methylene blue. Lasers Surg Med 42(8):728–735

    Article  PubMed Central  PubMed  Google Scholar 

  37. Morton C, McKenna K, Rhodes L (2008) Guidelines for topical photodynamic therapy: update. Br J Dermatol 159(6):1245–1266

    Article  CAS  PubMed  Google Scholar 

  38. Braathen LR et al (2007) Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International society for photodynamic therapy in dermatology, 2005. J Am Acad Dermatol 56(1):125–143

    Article  PubMed  Google Scholar 

  39. Morton CA, et al. (2012) European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol

  40. Morton CA, et al. (2012) European guidelines for topical photodynamic therapy part 2: emerging indications - field cancerization, photorejuvenation and inflammatory/infective dermatoses. J Eur Acad Dermatol Venereol

  41. Grapengiesser S et al (2002) Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 27(6):493–497

    Article  CAS  PubMed  Google Scholar 

  42. Zelickson BD (2005) Mechanisms of action of topical aminolevulinic acid. Photodynamic Therapy. 1st ed. Philadelphia: Elsevier Saunders, p. 1–12.

  43. Kalka K, Merk H, Mukhtar H (2000) Photodynamic therapy in dermatology. J Am Acad Dermatol 42(3):389–413, quiz 414–6

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nevien A. Samy.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Samy, N.A., Salah, M.M., Ali, M.F. et al. Effect of methylene blue-mediated photodynamic therapy for treatment of basal cell carcinoma. Lasers Med Sci 30, 109–115 (2015). https://doi.org/10.1007/s10103-014-1609-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10103-014-1609-1

Keywords

Navigation